You may leave me a review on these links:

Dr Toby A. Eyre

  • MBChB (Hons), DipMedEd, MRCP (UK), FRCPath (UK), MD (University of Newcastle)
  • Consultant Haematologist


Clinical interests

Lymphoma and lymphoprofilerative disorders
Chronic lymphocytic leukaemia

Professional memberships

  • MRCP (UK)
  • FRCPath (UK)
  • British society of haematology

Publications and affiliations

  • Prognostication in Richter syndrome: context is everything. 2020 May 18
  • DPACE-based chemotherapy in the era of myeloma novel agents: a UK multicentre study. 2020 Apr 8
  • Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival. 2020 Mar 31
  • Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK inhibition as an Effective Strategy. Clin Cancer Res. 2020 Mar 20
  • Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients. PLoS One. 2020 Feb 21

Dr Toby A. Eyre's reviews